Pires CA, Cruz NF, Lobato AM, Sousa PO, Carneiro FR, Mendes AM. Clinical, epidemiological, and therapeutic profile of dermatophytosis. An Bras Dermatol. 2014 Mar-Apr. 89(2):259-64. [QxMD MEDLINE Link]. [Full Text].
Jain S, Kabi S, Swain B. Current Trends of Dermatophytosis in Eastern Odisha. J Lab Physicians. 2020 Mar. 12 (1):10-14. [QxMD MEDLINE Link].
Yee G, Al Aboud AM. Tinea Corporis. StatPearls [Internet]. 2020 Jan. [QxMD MEDLINE Link]. [Full Text].
Leung AK, Lam JM, Leong KF, Hon KL. Tinea corporis: an updated review. Drugs Context. 2020. 9:[QxMD MEDLINE Link].
Adams BB. Tinea corporis gladiatorum. J Am Acad Dermatol. 2002 Aug. 47(2):286-90. [QxMD MEDLINE Link].
Ilkit M, Saracli M, Kurdak H, et al. Clonal outbreak of Trichophyton tonsurans tinea capitis gladiatorum among wrestlers in Adana, Turkey. Med Mycol. 2009 Oct 14. [QxMD MEDLINE Link].
Sun PL, Ho HT. Concentric rings: an unusual presentation of tinea corporis caused by Microsporum gypseum. Mycoses. 2006 Mar. 49(2):150-1. [QxMD MEDLINE Link].
Sanchez-Castellanos ME, Mayorga-Rodriguez JA, Sandoval-Tress C, Hernandez-Torres M. Tinea incognito due to Trichophyton mentagrophytes. Mycoses. 2007 Jan. 50(1):85-7. [QxMD MEDLINE Link].
Seyfarth F, Ziemer M, Gräser Y, Elsner P, Hipler UC. Widespread tinea corporis caused by Trichophyton rubrum with non-typical cultural characteristics--diagnosis via PCR. Mycoses. 2007. 50 Suppl 2:26-30. [QxMD MEDLINE Link].
Leyden J. Pharmacokinetics and pharmacology of terbinafine and itraconazole. J Am Acad Dermatol. 1998 May. 38(5 Pt 3):S42-7. [QxMD MEDLINE Link].
Singh S, Shukla P. End of the road for terbinafine? Results of a pragmatic prospective cohort study of 500 patients. Indian J Dermatol Venereol Leprol. 2018 Jun 8. [QxMD MEDLINE Link].
Singh A, Masih A, Khurana A, Singh PK, Gupta M, Hagen F, et al. High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene. Mycoses. 2018 Jul. 61 (7):477-484. [QxMD MEDLINE Link].
Sardana K, Kaur R, Arora P, Goyal R, Ghunawat S. Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre?. Indian Dermatol Online J. 2018 Mar-Apr. 9 (2):90-95. [QxMD MEDLINE Link].
Mapelli ET, Borghi E, Cerri A, Sciota R, Morace G, Menni S. Tinea corporis due to Trichophyton rubrum in a Woman and Tinea capitis in her 15-Day-Old Baby: Molecular Evidence of Vertical Transmission. Mycopathologia. 2011 Oct 14. [QxMD MEDLINE Link].
Shiraki Y, Hiruma M, Matsuba Y, et al. A case of tinea corporis caused by Arthroderma benhamiae (teleomorph of Tinea mentagrophytes) in a pet shop employee. J Am Acad Dermatol. 2006 Jul. 55(1):153-4. [QxMD MEDLINE Link].
Placzek M, van den Heuvel ME, Flaig MJ, Korting HC. Perniosis-like tinea corporis caused by Trichophyton verrucosum in cold-exposed individuals. Mycoses. 2006 Nov. 49(6):476-9. [QxMD MEDLINE Link].
Foster KW, Ghannoum MA, Elewski BE. Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. J Am Acad Dermatol. 2004 May. 50(5):748-52. [QxMD MEDLINE Link].
Carod JF, Ratsitorahina M, Raherimandimby H, Hincky Vitrat V, Ravaolimalala Andrianaja V, Contet-Audonneau N. Outbreak of Tinea capitis and corporis in a primary school in Antananarivo, Madagascar. J Infect Dev Ctries. 2011 Oct 13. 5(10):732-6. [QxMD MEDLINE Link].
Hryncewicz-Gwózdz A, Beck-Jendroschek V, Brasch J, Kalinowska K, Jagielski T. Tinea capitis and tinea corporis with a severe inflammatory response due to Trichophyton tonsurans. Acta Derm Venereol. 2011 Oct. 91(6):708-10. [QxMD MEDLINE Link].
Seyfarth F, Goetze S, Erhard M, Burmester A, Elsner P, Hipler UC. [Infection with a rare geophilic dermatophyte.]. Hautarzt. 2009 Aug 14. [QxMD MEDLINE Link].
Yehia MA, El-Ammawi TS, Al-Mazidi KM, Abu El-Ela MA, Al-Ajmi HS. The Spectrum of Fungal Infections with a Special Reference to Dermatophytoses in the Capital Area of Kuwait During 2000-2005: A Retrospective Analysis. Mycopathologia. 2009 Nov 17. [QxMD MEDLINE Link].
Dhib I, Khammari I, Yaacoub A, Hadj Slama F, Ben Saïd M, Zemni R, et al. Relationship Between Phenotypic and Genotypic Characteristics of Trichophyton mentagrophytes Strains Isolated from Patients with Dermatophytosis. Mycopathologia. 2017 Jun. 182 (5-6):487-493. [QxMD MEDLINE Link].
Ziemer M, Seyfarth F, Elsner P, Hipler UC. Atypical manifestations of tinea corporis. Mycoses. 2007. 50 Suppl 2:31-5. [QxMD MEDLINE Link].
Kim HS, Cho BK, Oh ST. A case of tinea corporis purpurica. Mycoses. 2007 Jul. 50(4):314-6. [QxMD MEDLINE Link].
Romano C, Massai L, Strangi R, Feci L, Miracco C, Fimiani M. Tinea corporis purpurica and onychomycosis caused by Trichophyton violaceum. Mycoses. 2009 Sep 22. [QxMD MEDLINE Link].
Weinstein A, Berman B. Topical treatment of common superficial tinea infections. Am Fam Physician. 2002 May 15. 65(10):2095-102. [QxMD MEDLINE Link].
Tsunemi Y. Oral Antifungal Drugs in the Treatment of Dermatomycosis. Med Mycol J. 2016. 57 (2):J71-5. [QxMD MEDLINE Link].
Chatterjee D, Ghosh SK, Sen S, Sarkar S, Hazra A, De R. Efficacy and tolerability of topical sertaconazole versus topical terbinafine in localized dermatophytosis: A randomized, observer-blind, parallel group study. Indian J Pharmacol. 2016 Nov-Dec. 48 (6):659-664. [QxMD MEDLINE Link].
Choudhary S, Bisati S, Singh A, Koley S. Efficacy and Safety of Terbinafine Hydrochloride 1% Cream vs. Sertaconazole Nitrate 2% Cream in Tinea Corporis and Tinea Cruris: A Comparative Therapeutic Trial. Indian J Dermatol. 2013 Nov. 58(6):457-60. [QxMD MEDLINE Link]. [Full Text].
Liebel F, Lyte P, Garay M, Babad J, Southall MD. Anti-inflammatory and anti-itch activity of sertaconazole nitrate. Arch Dermatol Res. 2006 Sep. 298(4):191-9. [QxMD MEDLINE Link].
Brooks, M. FDA Approves New Topical Antifungal Luliconazole 1%. Medscape Medical News. Available at http://www.medscape.com/viewarticle/814470. Accessed: November 18, 2013.
Luzu (luliconazole topical cream 1%) [package insert]. Bridgewater, NJ: Valeant Pharmaceuticals North America LLC. February, 2018. Available at [Full Text].
Mahajan S, Tilak R, Kaushal SK, Mishra RN, Pandey SS. Clinico-mycological study of dermatophytic infections and their sensitivity to antifungal drugs in a tertiary care center. Indian J Dermatol Venereol Leprol. 2017 Jul-Aug. 83 (4):436-440. [QxMD MEDLINE Link].
Schreuder MF, van de Kar NC, Brüggemann RJ. Drug-Drug Interactions in Treatment Using Azole Antifungal Agents. JAMA. 2016 Jun 21. 315 (23):2622. [QxMD MEDLINE Link].
Chen S, Ran Y, Dai Y, Lama J, Hu W, Zhang C. Administration of Oral Itraconazole Capsule with Whole Milk Shows Enhanced Efficacy As Supported by Scanning Electron Microscopy in a Child with Tinea Capitis Due to Microsporum canis. Pediatr Dermatol. 2015 Oct 8. [QxMD MEDLINE Link].
da Silva Barros ME, de Assis Santos D, Soares Hamdan J. Antifungal susceptibility testing of Trichophyton rubrum by E-test. Arch Dermatol Res. 2007 May. 299(2):107-9. [QxMD MEDLINE Link].
Wingfield AB, Fernandez-Obregon AC, Wignall FS, Greer DL. Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole. Br J Dermatol. 2004 Jan. 150(1):119-26. [QxMD MEDLINE Link].
Eusebio-Alpapara KMV, Dofitas BL, Balita-Crisostomo CLA, Tioleco-Ver GMS, Jandoc LE, Frez MLF. Senna (Cassia) alata (Linn.) Roxb. leaf decoction as a treatment for tinea imbricata in an indigenous tribe in Southern Philippines. Mycoses. 2020 Aug 10. [QxMD MEDLINE Link].
Majid I, Sheikh G, Kanth F, Hakak R. Relapse after Oral Terbinafine Therapy in Dermatophytosis: A Clinical and Mycological Study. Indian J Dermatol. 2016 Sep-Oct. 61 (5):529-33. [QxMD MEDLINE Link].
Diep D, Calame A, Cohen PR. Tinea Corporis Masquerading as a Diffuse Gyrate Erythema: Case Report and a Review of Annular Lesions Mimicking a Dermatophyte Skin Infection. Cureus. 2020 Jun 30. 12 (6):e8935. [QxMD MEDLINE Link].